期刊文献+

股浅动脉首期置入自膨式支架与球囊扩张成形的疗效比较 被引量:6

Primary implantation of a self-expanding nitinol stent versus percutaneous trausluminal angioplasty for arteriosclerosis obliterans of superficial femoral artery
原文传递
导出
摘要 目的比较股浅动脉狭窄闭塞长段病变一期置入自膨式支架与一期球囊扩张成形的中期疗效。方法回顾性分析2005年12月至2007年2月收治的症状性股浅动脉硬化狭窄或闭塞109例患者的临床资料,其中支架组53例(73条肢体)首期置入自膨式支架;扩张组56例(76条肢体)首期单纯球囊扩张成形。比较患者术后6、12及24个月的再狭窄、再闭塞率及临床分级改善程度。结果支架组与扩张组的治疗段平均长度分别为(16±8)cm和(15±7)cm;经血管超声检查支架组与扩张组术后6个月再狭窄率分别为13.7%(7例)和30.2%(16例),两组差异有统计学意义(χ^2=4.09,P〈0.05);12个月分别为25.5%(12例)和46.9%(23例),两组差异有统计学意义(χ^2=4.75,P〈0.05);24个月分别为38.1%(16例)和65.9%(29例),两组差异有统计学意义(χ^2=6.66,P〈0.01);且支架组较扩张组临床分级改善显著而持久。结论对于股浅动脉硬化狭窄或闭塞长段病变,首期置入自膨式支架的中期疗效较单纯球囊扩张血管成形术更为理想。 Objective To compare the mid-term clinical results of primary implantation of a self- expanding nitinol stent and primary percutaneous transluminal angioplasty (PTA) for long range arteriosclerosis obliterans of the superficial femoral artery. Methods From December 2005 to February 2007,109 patients who had moderate-severe claudication or chronic limb ischemia (CLI)due to stenosis or occlusion of the superficial femoral artery were treated by endovascular technology. 53 patients ( 73 limbs ) were treated by primary stenting and 56 patients (76 limbs)by PTA. We compared the clinical data of stenting group and PTA group at 6,12 and 24 months. Results The mean length of the treated segment was ( 16 ± 8 ) cm in the stenting group and( 15 ± 7 ) em in the PTA group. At 6 months, the rate of restenosis on duplex ultrasonography was 13.7% in stenting group and 30. 2% in PTA group ( χ^2 = 4. 09, P 〈 0. 05 ) ; at 12 months the restenosis rates were 25.5% in stenting group and 46. 9% in PTA group( χ^2 = 4. 75 ,P 〈 0. 05 ) ; at 24 months the restenosis rates on duplex uhrasonography were 38. 1% in stenting group and 65.9% in PTA group (χ^2 = 6. 66, P 〈 0. 01 ). Rutherford stages in stenting group were significantly better than those in PTA group. Conclusion In the mid-term, primary implantation of a self-expanding nitinol stent yielded results that were superior to those with PTA for arteriosclerosis obliterans or long range stenosis of the superficial femoral artery.
出处 《中华普通外科杂志》 CSCD 北大核心 2009年第6期455-458,共4页 Chinese Journal of General Surgery
关键词 动脉硬化 闭塞性 支架 移植物闭塞 血管 股动脉 Arteriosclerosis obliterans Stents Graft occlusion, vascular Femoral artery
  • 相关文献

参考文献10

  • 1Dormandy JA, Rutherford B. Management of peripheral arterial disease(PAD). J Vasc Surg,2000,31 : 1-296.
  • 2Minar E,Pokrajac B, Maca T,et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation, 2000, 102 : 2694 -2699.
  • 3Henry M,Amor M,Beyar l,et al. Clinical experience with a new nitinol self-expanding stent in peripheral artery. J Endovasc Surg, 1996,3:369-379.
  • 4Jack L, Peter G, Wayne J. Rutherford Vascular Surgery (Fifth Edition).北京:人民卫生出版社,2002:928-943.
  • 5Cejna M,Tumher S,Illiasch H,et al. PTA versus Palmaz stent in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol, 2001,12:23-31.
  • 6Grimm J, Muller-Hulsbeck S, Jahnke T, et al. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol, 2001,12: 935 -942.
  • 7Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society consensus for the management of peripheral arterial disease. Int A ngiol, 2007,26 : 81 - 157.
  • 8Schilllnger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med,2006,354:1879-1888.
  • 9Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO Ⅱ trial. J Vasc Interv Radiol, 2005,16: 331-338.
  • 10Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coil Cardiol, 2005,45:312-315.

同被引文献47

  • 1马鲁波,刘剑刚,史大卓,王永炎,李秀玲,梁鑫淼.气血并治方及其配伍对高脂血症血瘀大鼠血管活性物质的影响[J].中国实验方剂学杂志,2006,12(4):32-35. 被引量:10
  • 2周明学,徐浩.不稳定动脉粥样硬化斑块的中医药治疗概况[J].中国中西医结合杂志,2006,26(5):472-474. 被引量:14
  • 3Jeffrey W,Olin DO.Thromboangiitis obliterans (Buerger's disease) in Rutherford:vascular surgery[M].5th ed.Philadelphia:WB Saunders,2000:350-364.
  • 4Paraskevas KI,Liapis CD,Briana DD,et al.Thromboangiitis obliterans (Buerger's disease):searching for a therapeutic strategy[J].Angiology,2006,58(1):75-84.
  • 5Shionoya S.Buerger's disease:the diagnosis and management[J].Cardiovasc Surg,1993,1(3):207-214.
  • 6Bozkurt AK,Koksal C,Ercan M.The altered hemorheologic parameters in thromboangiitis obliterans:a new insight[J].Clin Appl Thromb Hemost,2004,10(1):45-50.
  • 7Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) [J]. Eur J Vasc Endovasc Surg,2007, 33(Suppl) :S1 - S75.
  • 8Blevins WA Jr, Schneider PA. Endovascular management of critical'limb isehemia[J]. Eur J Vasc Endovasc Surg, 2010,39 (6) : 756 - 761.
  • 9Aronow WS. Peripheral arterial disease in the elderly[J]. Clin Interv Aging, 2007,2(4) : 645 - 654.
  • 10Almahameed A,Bhatt DL. Contemporary management of peripheral arterial disease: [J]. Endovascular and surgical management[J]. Cleve Clin J Med, 2006,73 (Suppl 4) : S45 - 51.

引证文献6

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部